Cargando…
Discovery of a novel nonsteroidal selective glucocorticoid receptor modulator by virtual screening and bioassays
Synthetic glucocorticoids (GCs) have been widely used in the treatment of a broad range of inflammatory diseases, but their clinic use is limited by undesired side effects such as metabolic disorders, osteoporosis, skin and muscle atrophies, mood disorders and hypothalamic-pituitary-adrenal (HPA) ax...
Autores principales: | Pang, Jin-ping, Hu, Xue-ping, Wang, Yun-xia, Liao, Jia-ning, Chai, Xin, Wang, Xu-wen, Shen, Chao, Wang, Jia-jia, Zhang, Lu-lu, Wang, Xin-yue, Zhu, Feng, Weng, Qin-jie, Xu, Lei, Hou, Ting-jun, Li, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809242/ https://www.ncbi.nlm.nih.gov/pubmed/35110698 http://dx.doi.org/10.1038/s41401-021-00855-6 |
Ejemplares similares
-
Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays
por: Zhou, Wenfang, et al.
Publicado: (2018) -
The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay
por: Xia, Jie, et al.
Publicado: (2018) -
Discovery of Novel ROCK1 Inhibitors via Integrated Virtual Screening Strategy and Bioassays
por: Shen, Mingyun, et al.
Publicado: (2015) -
Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
por: Ricciotti, Emanuela, et al.
Publicado: (2021) -
Discovery of human TyrRS inhibitors by structure-based virtual screening, structural optimization, and bioassays
por: Huang, Shenzhen, et al.
Publicado: (2019)